Education
About Us
Working with TipRanks
Follow Us
ABOT - ETF AI Analysis
Top Page
Donoghue Forlines Innovation ETF (ABOT)
Rating:72Outperform
Price Target:―
Positive Factors
Focused Innovation Theme
The fund concentrates on innovative companies in areas like technology and health care, aiming to benefit if these growth themes do well over time.
Sector Diversification Within Growth Areas
Holdings are spread across several growth-oriented sectors, which helps avoid relying on just one industry for returns.
Moderate Expense Ratio
The fund’s fee is moderate for an actively themed ETF, so costs are not excessively high relative to its specialized focus.
Negative Factors
Recent Weak Performance
The ETF has shown weak returns over the past month, three months, and year to date, which may concern investors looking for near-term strength.
Heavy Tilt Toward Technology
A large share of the portfolio is in technology stocks, making the fund sensitive to downturns in that sector.
Underperforming Top Holdings
Several of the largest positions, including well-known names like Apple, Nvidia, and Adobe, have recently lagged, weighing on the fund’s overall results.
ABOT vs. SPDR S&P 500 ETF (SPY)
AUM4.34M
RegionNorth America
Expense Ratio0.39%
Beta1.15
IssuerAbacus
Inception DateDec 07, 2020
Dividend Yield0.43%
Asset ClassEquity
Index TrackedFCF US Quality Innovation Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume997
30 Day Avg. Volume410
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.42Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering49
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABOT Summary
The Donoghue Forlines Innovation ETF (ABOT) follows the FCF US Quality Innovation Index, focusing on innovative U.S. companies across the total stock market. It leans heavily toward technology, but also includes health care, communication services, and consumer companies. Well-known holdings include Nvidia and Apple, along with other major tech and health care names. Someone might invest in ABOT to seek long-term growth and diversification in innovative businesses while still spreading risk across many stocks. A key risk is that it is heavily tilted toward tech, so its price can swing sharply with changes in the technology sector and overall market.
How much will it cost me?The Donoghue Forlines Innovation ETF (ABOT) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on innovative strategies and a diverse mix of companies across sectors. Active management typically involves more research and decision-making, which can lead to higher costs.
What would affect this ETF?The Donoghue Forlines Innovation ETF (ABOT) could benefit from continued advancements in technology and healthcare, as these sectors make up a significant portion of its holdings. However, rising interest rates or regulatory changes in the U.S., where the fund is heavily focused, could negatively impact growth-oriented companies like Apple and Nvidia. Economic conditions and shifts in consumer spending may also influence the performance of its consumer cyclical and communication services holdings.
ABOT Top 10 Holdings
ABOT is leaning hard into U.S. innovation, with a tech-heavy lineup that makes semiconductors and software the main engines of performance. Alphabet has been one of the fund’s bright spots lately, helping offset a softer patch for Nvidia and Broadcom, where momentum has cooled despite strong AI stories. Apple and Adobe look like they’re losing steam, adding drag rather than lift. Health care names like AbbVie and Bristol-Myers offer a steadier counterweight, but this ETF still lives and dies mostly by its big U.S. tech bets.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nvidia | 6.10% | $264.74K | $4.44T | 31.66% | 76 Outperform | |
| Apple | 5.62% | $243.82K | $3.76T | 4.57% | 79 Outperform | |
| Broadcom | 3.84% | $166.58K | $1.54T | 39.53% | 76 Outperform | |
| Alphabet Class A | 3.54% | $153.61K | $3.70T | 65.05% | 85 Outperform | |
| Bristol-Myers Squibb | 3.22% | $139.76K | $123.70B | 12.69% | 78 Outperform | |
| AbbVie | 3.02% | $131.21K | $409.15B | 20.03% | 66 Neutral | |
| Airbnb | 2.64% | $114.77K | $74.49B | -24.82% | 71 Outperform | |
| Amgen | 2.60% | $112.91K | $198.80B | 25.77% | 77 Outperform | |
| Qualcomm | 2.53% | $110.01K | $150.13B | -18.31% | 80 Outperform | |
| Gilead Sciences | 2.39% | $103.61K | $192.28B | 48.90% | 78 Outperform |
ABOT Technical Analysis
Negative
―
Price Trends
37.98
Negative
39.01
Negative
38.52
Negative
Market Momentum
-1.07
Positive
33.48
Neutral
23.13
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABOT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 35.87, equal to the 50-day MA of 37.98, and equal to the 200-day MA of 38.52, indicating a bearish trend. The MACD of -1.07 indicates Positive momentum. The RSI at 33.48 is Neutral, neither overbought nor oversold. The STOCH value of 23.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ABOT.
ABOT Peer Comparison
Comparison Results
Performance Comparison
ABOT
Donoghue Forlines Innovation ETF
34.34
-4.44
-11.45%
BAMD
Brookstone Dividend Stock ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
BUZZ
VanEck Social Sentiment ETF
―
―
―
TMFE
Motley Fool Capital Efficiency 100 Index ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents